Erythrocyte caspase-3 levels in children with chronic kidney disease

D Polak-Jonkisz1, L Purzyc, M Szcepańska

  • 1Department of Paediatric Nephrology, Wroclaw Medical University, ul. Borowska 213, 50-556 Wroclaw, Poland. dorota.polak-jonkisz@am.wroc.pl

Clinical Biochemistry
|October 30, 2012
PubMed

Insights

Red blood cell (RBC) aging in children with chronic kidney disease (CKD) increases with disease progression. Caspase-3 activity rises, while lactate dehydrogenase (LDH) and ATP levels decline in late-stage CKD, indicating energy imbalance.

Area of Science:

  • Biochemistry
  • Hematology
  • Nephrology

Background:

  • Chronic kidney disease (CKD) alters red blood cell (RBC) structure and metabolism.
  • Factors like uremic toxins induce premature RBC aging and apoptosis in CKD patients.
  • Understanding cellular responses in CKD is crucial for managing disease progression.

Purpose of the Study:

  • To evaluate caspase-3 activity, lactate dehydrogenase (LDH) levels, and adenosine triphosphate (ATP) concentrations in erythrocytes of children with CKD.
  • To correlate these erythrocyte parameters with the progression of chronic kidney disease.

Main Methods:

  • Spectrophotometric assays were used to measure caspase-3 and LDH activity in hemolyzed erythrocytes.
  • Adenosine triphosphate (ATP) concentrations were determined using a luciferin-luciferase kit.
  • Sixty CKD children (Stages I-IV) and 25 healthy children were included.

Main Results:

  • Lactate dehydrogenase (LDH) and ATP levels gradually increased from CKD Stage I to III, but decreased significantly in Stage IV compared to controls.
  • Caspase-3 activity was comparable to healthy children in Stage I and peaked in Stage III.
  • Stage IV CKD showed significantly lower LDH and ATP levels than the control group.

Conclusions:

  • Caspase-3 activity in RBCs of children with CKD increases as the disease progresses.
  • Decreased LDH activity and ATP concentration in Stage IV CKD suggest a compromised cellular energy balance.
  • These findings highlight significant alterations in RBC metabolism and integrity during CKD progression.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...